European Society for Medical Oncology (ESMO)

#ESMO23: Domenica Lorusso reports on key results from ESMO Congress 2023 on LBA38 - Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study
https://www.youtube.com/watch?v=yrVmH...

1 year ago | [YT] | 0